In last trading session, Matinas Biopharma Holdings Inc (AMEX:MTNB) saw 0.71 million shares changing hands with its beta currently measuring 1.55. Company’s recent per share price level of $0.64 trading at $0.06 or 9.97% at ring of the bell on the day assigns it a market valuation of $3.25M. That closing price of MTNB’s stock is at a discount of -3259.38% from its 52-week high price of $21.50 and is indicating a premium of 25.0% from its 52-week low price of $0.48.
Matinas Biopharma Holdings Inc (AMEX:MTNB) trade information
Upright in the green during last session for gaining 9.97%, in the last five days MTNB remained trading in the green while hitting it’s week-highest on Friday, 02/21/25 when the stock touched $0.64 price level, adding 14.67% to its value on the day. Matinas Biopharma Holdings Inc’s shares saw a change of 25.49% in year-to-date performance and have moved 6.67% in past 5-day. Matinas Biopharma Holdings Inc (AMEX:MTNB) showed a performance of 11.56% in past 30-days.
Matinas Biopharma Holdings Inc (MTNB) estimates and forecasts
This year revenue growth is estimated to fall -100.00% from the last financial year’s standing.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 7.12% during past 5 years.
Matinas Biopharma Holdings Inc (AMEX:MTNB)’s Major holders
HIGHBRIDGE CAPITAL MANAGEMENT LLC is the top institutional holder at MTNB for having 10.64 million shares of worth $1.68 million. And as of 2024-06-30, it was holding 4.8971 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 9.32 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.2869 of outstanding shares, having a total worth of $1.48 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 120.41 shares of worth $77063.0 or 2.37% of the total outstanding shares. The later fund manager was in possession of 58.39 shares on Sep 30, 2024 , making its stake of worth around $37367.0 in the company or a holder of 1.15% of company’s stock.
